Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19

Sala, Luca, Leonov, Vladislav, Mura, Manuela, Moretti, Alessandra, Crotti, Lia, Gnecchi, Massimiliano, Schwartz, Peter J.

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: The case of hydroxychloroquine in COVID-19

Sala, Luca, Leonov, Vladislav, Mura, Manuela, Moretti, Alessandra, Crotti, Lia, Gnecchi, Massimiliano, Schwartz, Peter J..

Vascular Pharmacology ; 146:N.PAG-N.PAG, 2022.

Article in English | Academic Search Complete | ID: covidwho-2061971

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Academic Search Complete Type of study: Experimental Studies Language: English Journal: Vascular Pharmacology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

Print

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: Academic Search Complete Type of study: Experimental Studies Language: English Journal: Vascular Pharmacology Year: 2022 Document Type: Article